What Happened?
Salt Lake City, UT-based Alucent Biomedical Appointed Jane Ren as Vice President of Research and Development and Chief Technology Officer
About the Company
Alucent Biomedical, Inc. is a privately held biotechnology company headquartered in Salt Lake City, Utah and is the first company to bring a novel, locally delivered biotechnology treatment to a market traditionally dominated by medical device solutions. Alucent was founded by Avera Health to develop and market Natural Vascular Scaffolding (NVS). NVS is a first-of-a-kind combination drug-device therapy designed to assist the body in naturally opening and maintaining arterial patency.
About the Person
Jane Ren is Vice President of Research and Development and Chief Technology Officer at Alucent Biomedical. Previously, Jane held various senior IT leadership roles in the industry.
Info Source
News
Short Profile